-
About Us
-
Fact Sheet
-
History
-
Management
-
Rocco Brunelle, M.S.
-
Ronald R. Bowsher, Ph.D.
-
Wendell C. Smith, Ph.D.
-
Mission
-
Bioanalytical & Ligand Binding Assays
-
Bioanalytical Statistics & Design-of-Experiments (DOE)
-
CRO Lab Selection & Bioanalytical Life-Cycle-Management
-
Ligand Binding Assays
-
Method Validation
-
Careers
-
Analytics
-
Consultants
-
IT / SAS Programmers
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Audit Conduct & Responses
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
GLP Compliance - SOPs, Quality Reviews and System Validations
-
Regulatory Sciences
-
Technical Writing
-
Clinical Trials Statistics & Outcomes Research
-
Analysis of Observational Data
-
Drug Safety - Demonstration of Risk vs. Benefit
-
Incremental Cost-Effectiveness (ICE) Analysis
-
PK/PD Support
-
Statistical Analyst & Programming Support
-
Statistical Support for all phases of Clinical Trials
-
CMC Support
-
Manufacturing & Regulatory Support
-
Preformulation, Formulation, & Analytical Methods Dev.
-
Contact
-
Services Request
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Anti-Drug Antibody (ADA) Assay Development & Validation
-
Preclinical / Clinical Immunogenicity Risk Assessment & Mitigation Planning
-
Preclinical Safety Testing / Immunotoxicology
-
Statistics for Screening & Confirmatory Cut-Points
-
Protein / Peptide Therapeutics & Biosimilars
-
ADME of Protein / Peptide Biotherapeutics
-
Biosimilars / Biocomparables
-
Insulin / Insulin Analogues
-
LC-MS Analysis
-
PK Data Analysis
-
Preclinical Toxicology / IND Support
-
Team
-
Consultants
-
Bioanalytical & Ligand Binding Assays
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
Quality Compliance
-
Regulatory Science
-
Clinical Trials Statistics & Outcomes Research
-
CMC Support
-
Dan Wierda, Ph.D.
-
Dennis Bowsher, M.D.
-
Erik Foehr, Ph.D.
-
Gordon Arbuthnot
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Immune Safety Testing / Immunotoxicology
-
Immunogenicity
-
Immunogenicity Statistics
-
Risk Assessment & Mitigation
-
Jeff Sailstad, B.S.
-
Marian Kelley, M.A.
-
Mark Staples, Ph.D.
-
Nagy Farid, Ph.D.
-
Paul Gesellchen, Ph.D., RAC
-
Protein / Peptide Therapeutics & Biosimilars
-
LC-MS Analysis
-
Richard Bergstrom, Ph.D.
-
Robert Obenchain, Ph.D.
-
Rose Sekulovich, Ph.D.
-
Staff
-
Andy Sponsler, M.S.
-
Ed Hacker, B.S.
-
Kristin Hardymon, M.A.
-
Philip Bowsher, B.S.
-
Shanna Northrup
-
Thank you
-
Thank you
| |
-
About Us
-
Fact Sheet
-
History
-
Management
-
Rocco Brunelle, M.S.
-
Ronald R. Bowsher, Ph.D.
-
Wendell C. Smith, Ph.D.
-
Mission
-
Bioanalytical & Ligand Binding Assays
-
Bioanalytical Statistics & Design-of-Experiments (DOE)
-
CRO Lab Selection & Bioanalytical Life-Cycle-Management
-
Ligand Binding Assays
-
Method Validation
-
Careers
-
Analytics
-
Consultants
-
IT / SAS Programmers
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Audit Conduct & Responses
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
GLP Compliance - SOPs, Quality Reviews and System Validations
-
Regulatory Sciences
-
Technical Writing
-
Clinical Trials Statistics & Outcomes Research
-
Analysis of Observational Data
-
Drug Safety - Demonstration of Risk vs. Benefit
-
Incremental Cost-Effectiveness (ICE) Analysis
-
PK/PD Support
-
Statistical Analyst & Programming Support
-
Statistical Support for all phases of Clinical Trials
-
CMC Support
-
Manufacturing & Regulatory Support
-
Preformulation, Formulation, & Analytical Methods Dev.
-
Contact
-
Services Request
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Anti-Drug Antibody (ADA) Assay Development & Validation
-
Preclinical / Clinical Immunogenicity Risk Assessment & Mitigation Planning
-
Preclinical Safety Testing / Immunotoxicology
-
Statistics for Screening & Confirmatory Cut-Points
-
Protein / Peptide Therapeutics & Biosimilars
-
ADME of Protein / Peptide Biotherapeutics
-
Biosimilars / Biocomparables
-
Insulin / Insulin Analogues
-
LC-MS Analysis
-
PK Data Analysis
-
Preclinical Toxicology / IND Support
-
Team
-
Consultants
-
Bioanalytical & Ligand Binding Assays
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
Quality Compliance
-
Regulatory Science
-
Clinical Trials Statistics & Outcomes Research
-
CMC Support
-
Dan Wierda, Ph.D.
-
Dennis Bowsher, M.D.
-
Erik Foehr, Ph.D.
-
Gordon Arbuthnot
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Immune Safety Testing / Immunotoxicology
-
Immunogenicity
-
Immunogenicity Statistics
-
Risk Assessment & Mitigation
-
Jeff Sailstad, B.S.
-
Marian Kelley, M.A.
-
Mark Staples, Ph.D.
-
Nagy Farid, Ph.D.
-
Paul Gesellchen, Ph.D., RAC
-
Protein / Peptide Therapeutics & Biosimilars
-
LC-MS Analysis
-
Richard Bergstrom, Ph.D.
-
Robert Obenchain, Ph.D.
-
Rose Sekulovich, Ph.D.
-
Staff
-
Andy Sponsler, M.S.
-
Ed Hacker, B.S.
-
Kristin Hardymon, M.A.
-
Philip Bowsher, B.S.
-
Shanna Northrup
-
Thank you
-
Thank you
| |
-
About Us
-
Fact Sheet
-
History
-
Management
-
Rocco Brunelle, M.S.
-
Ronald R. Bowsher, Ph.D.
-
Wendell C. Smith, Ph.D.
-
Mission
-
Bioanalytical & Ligand Binding Assays
-
Bioanalytical Statistics & Design-of-Experiments (DOE)
-
CRO Lab Selection & Bioanalytical Life-Cycle-Management
-
Ligand Binding Assays
-
Method Validation
-
Careers
-
Analytics
-
Consultants
-
IT / SAS Programmers
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Audit Conduct & Responses
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
GLP Compliance - SOPs, Quality Reviews and System Validations
-
Regulatory Sciences
-
Technical Writing
-
Clinical Trials Statistics & Outcomes Research
-
Analysis of Observational Data
-
Drug Safety - Demonstration of Risk vs. Benefit
-
Incremental Cost-Effectiveness (ICE) Analysis
-
PK/PD Support
-
Statistical Analyst & Programming Support
-
Statistical Support for all phases of Clinical Trials
-
CMC Support
-
Manufacturing & Regulatory Support
-
Preformulation, Formulation, & Analytical Methods Dev.
-
Contact
-
Services Request
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Anti-Drug Antibody (ADA) Assay Development & Validation
-
Preclinical / Clinical Immunogenicity Risk Assessment & Mitigation Planning
-
Preclinical Safety Testing / Immunotoxicology
-
Statistics for Screening & Confirmatory Cut-Points
-
Protein / Peptide Therapeutics & Biosimilars
-
ADME of Protein / Peptide Biotherapeutics
-
Biosimilars / Biocomparables
-
Insulin / Insulin Analogues
-
LC-MS Analysis
-
PK Data Analysis
-
Preclinical Toxicology / IND Support
-
Team
-
Consultants
-
Bioanalytical & Ligand Binding Assays
-
Clinical Drug Development, Pharmacokinetics & Modeling, & Regulatory & Quality
-
Clinical Drug Development
-
Clinical Pharmacology, Pharmacokinetics & Modeling
-
Quality Compliance
-
Regulatory Science
-
Clinical Trials Statistics & Outcomes Research
-
CMC Support
-
Dan Wierda, Ph.D.
-
Dennis Bowsher, M.D.
-
Erik Foehr, Ph.D.
-
Gordon Arbuthnot
-
Immunogenicity, Immune Safety Testing, & Risk Assessment & Mitigation
-
Immune Safety Testing / Immunotoxicology
-
Immunogenicity
-
Immunogenicity Statistics
-
Risk Assessment & Mitigation
-
Jeff Sailstad, B.S.
-
Marian Kelley, M.A.
-
Mark Staples, Ph.D.
-
Nagy Farid, Ph.D.
-
Paul Gesellchen, Ph.D., RAC
-
Protein / Peptide Therapeutics & Biosimilars
-
LC-MS Analysis
-
Richard Bergstrom, Ph.D.
-
Robert Obenchain, Ph.D.
-
Rose Sekulovich, Ph.D.
-
Staff
-
Andy Sponsler, M.S.
-
Ed Hacker, B.S.
-
Kristin Hardymon, M.A.
-
Philip Bowsher, B.S.
-
Shanna Northrup
-
Thank you
-
Thank you
| |